Summary

The companies have publicly supported independent evaluation, but Reuters reported that negotiations include restrictions intended to protect trade secrets and prevent information from moving between labs. Proposed safeguards include lab observation of evaluators and limits on simultaneous work for competing providers.

Why it matters

Independent testing only improves accountability if evaluators can disclose material findings, making publication control a central governance fault line.

Sources